Ушбу иш иқтибос қилган ишлар

98 та иш

Иш: Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Мақола20206 иқтибос
ABI
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy, Jeffrey W. Pollard
Шарҳ мақола20145 иқтибос
ABI
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Шарҳ мақола20245 иқтибос
ABI
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Шарҳ мақола20255 иқтибос
ABI
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
Hussein Sabit, Timothy M. Pawlik, Faisal F.Y. Radwan +6
Шарҳ мақола20254 иқтибос
ABI
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul, Girdhari Lal
Шарҳ мақола20173 иқтибос
ABI
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani +4
Шарҳ мақола20233 иқтибос
ABI
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
Renee B. Chang, Gregory L. Beatty
Шарҳ мақола20203 иқтибос
ABI
Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu +5
Шарҳ мақола20232 иқтибос
ABI
Understanding the tumor microenvironment for effective immunotherapy
Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani +4
Шарҳ мақола20202 иқтибос
ABI
Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1
Шарҳ мақола20202 иқтибос
ABI
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan +4
Мақола20212 иқтибос
ABI
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian +4
Шарҳ мақола20222 иқтибос
ABI
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
Yan Zhong, Jingfeng Liu
Мақола20242 иқтибос
ABI
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang, Ningning Guo, Yi Zhou +3
Шарҳ мақола20202 иқтибос
ABI
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
Ali Bashiri Dezfouli, Mina Yazdi, A. Graham Pockley +4
Шарҳ мақола20212 иқтибос
ABI
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Шарҳ мақола20232 иқтибос
ABI
Exploring the potential of CAR-macrophage therapy
Yongyu Shi, Xia Li, Yan Dong +3
Шарҳ мақола20242 иқтибос
ABI
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
Crescenzo D’Alterio, Stefania Scala, Gabriella Sozzi +2
Шарҳ мақола20192 иқтибос
ABI
Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
Tiffany D. Ricketts, Néstor Prieto‐Domínguez, Pramod S. Gowda +1
Шарҳ мақола20212 иқтибос
ABI
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Jing Gao, Yuanzheng Liang, Liang Wang
Шарҳ мақола20222 иқтибос
ABI
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Hans Raskov, Adile Orhan, Shruti Gaggar +1
Шарҳ мақола20212 иқтибос
ABI
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Шарҳ мақола20212 иқтибос
ABI
Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells
Junhui Guo, Ali Afzal, Sadia Ahmad +7
Шарҳ мақола20252 иқтибос
ABI
NK Cells in the Treatment of Hematological Malignancies
Ana Pilar González, Mónica Villa-Álvarez, Christian Sordo‐Bahamonde +2
Шарҳ мақола20192 иқтибос
ABI